A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis
Status:
Not yet recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This trial was performed in patients with idiopathic pulmonary fibrosis (IPF) to evaluate the
clinical efficacy and safety of different doses of TDI01 Suspension, compared with control,
for the treatment of patients with IPF.